IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 280 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $469,812 | +38.4% | 58,580 | +155.8% | 0.10% | +26.5% |
Q1 2024 | $339,378 | +53.0% | 22,900 | -16.1% | 0.08% | +48.2% |
Q4 2023 | $221,868 | +35.3% | 27,290 | +310.4% | 0.06% | +14.3% |
Q3 2021 | $164,000 | +290.5% | 6,650 | +310.5% | 0.05% | +308.3% |
Q2 2021 | $42,000 | -92.3% | 1,620 | -90.6% | 0.01% | -93.5% |
Q1 2021 | $549,000 | -42.3% | 17,326 | -15.4% | 0.19% | -39.2% |
Q4 2020 | $951,000 | -28.7% | 20,491 | -49.4% | 0.31% | -24.3% |
Q3 2020 | $1,333,000 | +332.8% | 40,481 | +260.6% | 0.40% | +359.1% |
Q2 2020 | $308,000 | +12.0% | 11,225 | +22.1% | 0.09% | -12.0% |
Q1 2020 | $275,000 | – | 9,190 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |